Summary Prior analysis of 20 human mesothelioma cell lines for p53 status revealed only two mutations and one p53 null cell line, although p53 expression was detected in most cell lines. In addition, mRNA and protein expression of the retinoblastoma gene product in human mesothelioma cell lines is similar to normal controls. We have tested for p53 induction after exposure to ionising radiation and demonstrate this induction and, to a lesser extent, p2IWAFI induction, in both normal mesothelial cells and p53-positive mesothelioma cell lines. We postulated that high levels of MDM2 might alter p53 and retinoblastoma tumour-suppressor function in mesothelioma. However, Southern blot analysis for mdm2 indicated that no amplification had occurred in 18 mesothelioma cell lines tested. Steady-state mRNA and protein levels also did not indicate overexpression. These results indicate that high levels of MDM2 are not responsible for inactivating the functions of wild-type p53 or the retinoblastoma gene product during the pathogenesis of malignant mesothelioma.
Mesothelioma, a cancer involving disregulation of mesothelial cell growth, has been linked epidemiologically to asbestos fibre exposure (Wagner 1960; Wagner and Berry, 1969; Craighead and Mossman, 1982) . The 20 -50 year duration of the latency period for this malignancy suggests that it is generated by a multistep process induced by fibre exposure and involving chromosome breakage, rearrangement and deletions (Barrett, 1991; Hei et al., 1992) , aneuploidy and mutations secondary to damage by reactive oxygen species (Mossman et al., 1986) . At a molecular level, the pathogenesis of the disease is likely to involve modulation of tumour-suppressor pathways that are critical for normal cellular regulation.
Alterations in the p53 tumour-suppressor gene have been identified as the most frequent genetic events in a wide variety of human cancers (Hollstein 1991; Levine et al., 1991; Vogelstein and Kinzler, 1992) . In addition, retinoblastoma (Rb) gene dysfunction has been implicated in carcinogenesis (Benedict et al., 1990) . The importance of p53 and Rb tumour-suppressor function is shown by the evolution, in DNA tumour viruses, of proteins which disrupt the function of these molecules. Interaction of p53 and Rb with SV40 T antigen (Farmer et al., 1992; Mietz et al., 1992; Jiang et al., 1993; DeCaprio et al., 1988) , adenovirus Ela and Elb (Yew and Berk, 1992; Whyte et al., 1988) , and papillomavirus E6 and E7 (Mietz et al., 1992; Dyson et al., 1989) has been shown to block wild-type functions of these molecules. Indeed, in recent work showing the presence, in mesothelioma specimens, of SV40 T antigen (Carbone et al., 1994) , the authors suggest that latent SV40 infection of mesothelial cells may contribute to development of mesothelioma.
In contrast, the cell lines studied in this report have been shown previously to be negative for SV40 T antigen in a study in which all cells were stained with the polyclonal antibody to SV40 T, Pab 416, as an isotype-matched negative control for the p53 antibodies, Pab 1801 A candidate cellular protein, mouse double-minute 2 (MDM2), was cloned from the tumorigenic cell line, 3T3DM, and shown to have oncogenic potential (CahillySnyder et al., 1987; Fakharzadeh et al., 1991) . MDM2, through its N terminus Oliner et al., 1993) , binds to the transactivation domain of p53 and interferes with its activity as a transcriptional activator (Zauberman et al., 1993; Finlay, 1993; Momand et al., 1992) . Furthermore, induction of transformed foci in rat embryo fibroblasts by overexpression of ras and MDM2 is reduced by 50% by cotransfection with a wild-type p53 vector, and transformed cells express low levels of the wild-type p53 protein (Finlay, 1993) . Overexpression of mdm2, in the presence of wild-type p53, has been demonstrated in metastatic osteosarcomas (Ladanyi et al., 1993) , a low percentage of non-small-cell lung carcinomas (Marchetti et al., 1995) , a subset of human malignant gliomas (Reifenberger et al., 1993) and human leukaemias (Bueso-Ramos et al., 1993; Quesnel et al., 1994; Zhou et al., 1995) .
The mdm2 gene, in mouse, has been shown to produce several sets of proteins Barak et al., 1993) resulting from alternative splicing (Wu et al., 1993; , and/or alternative promoter usage (Barak et al., 1994) . It has been shown that initiation of translation from the third and fourth initiation codons results in molecules unable to bind to p53 Haines et al., 1994) . The conservation of a p53-responsive element leading to alternative transcripts has been demonstrated in the human mdm2 gene (Zauberman et al., 1995) , but its protein products remain to be characterised.
It has been suggested that MDM2 species that bind to p53 may be involved in an autoregulatory feedback loop (Wu et al., 1993; Perry et al., 1993; Barak et al., 1994; Picksley and Lane, 1993) . This feedback control would function by stimulation of mdm2 transcription by p53 from the p53-dependent promoter in intron 1, as opposed to the constitutive, upstream promoter (Wu et al., 1993; Barak et al., 1994; Zauberman et al., 1995) . Increased levels of MDM2 protein reduce p53 stimulation of the p53 response element in the mdm2 gene (Wu et al., 1993) , and inhibit the ability of irradiated colorectal carcinoma (RKO) and osteosarcoma (OSA-Cl) cell lines to arrest in the GQ stage of the cell cycle Meeren et al., 1993) . In addition, the presence of immunohistochemically detectable Rb protein in paraffinembedded tissue from human mesothelioma specimens and normal human mesothelium has been reported (Ramael et al., 1994) al., 1988) . Detailed information on the history and derivation of the M prefix cell lines has been reported previously (Metcalf et al., 1992) . Primary cultures of NHM cells were obtained from patients with non-malignant disease and initiated as described (LaVeck et al., 1988) . OSACl, a sarcoma cell line lacking p53 mutation (Leach et al., 1993) but exhibiting a 30-to 40-fold mdm 2 gene amplification as well as overexpression of both mdm2 mRNA and protein (Oliner et al., 1992) , was generously supplied by Dr Bert Vogelstein. This cell line, as well as human bronchial fibroblastic (HBF) cell strains, was maintained in Hut medium (Roswell Park Memorial Institute 1640 medium containing 10% fetal bovine serum; BioFluids, Rockville, MD, USA). Normal human bronchial epithelial (NHBE) cells were grown in LHC9 medium (BioFluids Inc.) as described previously (Maniatis ct al., 1982) . Membranes were probed with an f3'P-labelled nmdnI2 cDNA fragment, as described for RNA analysis. DNA loading and integrity were verified by reprobing with a randonm primed "P-labelled 900 bp Sau3AI fragmenit of the human single copy gene, J,,, generously provided by Dr Philip Leder (Ravetch et al., 1981a (Metcalf et al., 1992) were compared with NHM and the p53 null cell line, VAMT-1, for induction of' nuclear p53 and p2l1Al in response to ionising radiation. Figure 3) were evaluated for steady-state levels of mdm2 mRNA. All of these specimens revealed a single message of 5.5 kb, consistent with the size of mdm2 mRNA previously reported (Ladanyi et al., 1993; Oliner et al., 1992) (Figure 3) . The presence of multiple mRNA species (Zauberman et al., 1995) was not detected in these cells. Analysis of the four NHM revealed a range of mdm2 mRNA levels with three samples from 1.4 to 3.6 as much mRNA as VAMT-1, and one outlier at a 10.5-fold excess (Table I) . Nothing in the donor history or culture characteristics of this NHM culture explained this observation. Steady-state levels of MDM2 mRNA in the malignant mesothelioma cell lines ranged from 1.1 to 5.1, relative to VAMT-1 (Figure 3 , Table I ). Figure 4) . A single band of 90 kDa (Figure 3) , similar in size to that previously reported for the MDM2 protein product (Leach et al., 1993; Oliner et al., 1992; Barak and Oren, 1992; Momand et al., 1992; and consistent with the single mRNA species, was observed in all samples tested. The five NHM cell samples demonstrated a protein range of 1.2 to 9.8, relative to HBF (data not shown) with the highest value corresponding to the cell strain with the highest mRNA level. The 18 malignant mesothelioma cell lines exhibited protein levels ranging from 0.1 to 5.8, relative to HBF (Table I ). In general, the level of Meeren et al., 1993; Ramael et al., 1994) (Figure 4 ) and that p53 mutation is an infrequent event (Metcalf et al., 1992 Pietenpol and Vogelstein, 1993) .
Rb also has been found to interact with cellular protooncogenes, cell cycle-related proteins and other transcriptional factors, such as c-myc, N-myc, ATF-2, cdc2 proteins (for review see Goodrich and Lee, 1993) , cyclin D2 and cyclin-dependent kinase 4 (CDK4) (Ewen et al., 1993) . In addition, alterations of proteins that modulate the activity of these Rb-binding proteins, such as p16INK4, which inhibits CDK4 phosphorylation of Rb (Ewen et al., 1993) , could be cellular components that participate in the loss of cell cycle regulation. Recent data indicate that a large proportion of mesothelioma cell lines (Okamoto et al., 1994; Cheng et al., 1994) , as well as primary mesothelioma tumours (Xiao, S et al., 1995; Cheng 1994) , have homozygous deletions of the p16 gene. Further studies of p16INK4 in primary mesothelioma tumours will be necessary to evaluate the physiological significance of the loss of p16INK4. In addition, other targets in these tumour-suppressor pathways need to be evaluated to advance the understanding of the pathogenesis of mesothelioma.
